Skip to main content

Table 6 Therapeutic modification and outcomes of patients with hematologic malignancies and solid tumors.

From: Etiologies, diagnostic strategies, and outcomes of diffuse pulmonary infiltrates causing acute respiratory failure in cancer patients: a retrospective observational study

 

Hematologic (n= 115, 54%)

Solid (n= 99, 46%)

P value

Therapeutic modification

62 (54)

37 (37)

0.016

   Initiation of antimicrobial agents

40

19

 

   Change of antimicrobial agents

8

1

 

   Withdrawal of antimicrobial agents

10

5

 

   Initiation of steroid

3

11

 

   Initiation of chemotherapy

1

1

 

End-of-life decision

0

10 (10)

<0.001

Outcomes

   

   ICU mortality

33 (29)

31 (31)

0.677

   Length of stay in ICU (days)

5 (2-10)

7 (3-16)

0.008

   In-hospital mortality

55 (48)

50 (51)

0.696

   Length of stay in hospital (days)

31 (17-59)

22 (12-34)

0.004

   90-day mortality

68 (59)

70 (71)

0.078

  1. ICU, intensive care units.